Paediatric Expansion Primex has a novel oral solution for paediatric sedation approved in multiple EU markets, signaling a strong expansion into pediatric anaesthesia. Target pediatric hospitals, surgical centers, and ambulatory surgery networks with the paediatric portfolio and explore cross-sell opportunities into the broader anaesthesia product line.

EU Manufacturing All products are manufactured in Europe, providing regulatory alignment and reliable supply to EU hospital procurement teams. Leverage regional manufacturing as a selling point for faster onboarding, supply confidence, and compliant sourcing across multi-country hospital networks.

Global Partner Network A global partner network operating in many countries creates ready channels for market entry and co-marketing. Map key geographies where partners are active and propose joint commercialization plans to accelerate penetration in those markets.

OGNA Cross Sell In addition to anaesthesia, OGNA branded local anaesthetics and dental products enable cross-selling into dental clinics and hospital dental departments. Propose bundled solutions for oral surgery centers and anesthesia-driven dental procedures.

Growth Signals Recent leadership hire in business development and active participation in high-profile conferences signal a growth-focused strategy. Use upcoming events and the new BD leadership as triggers for outreach to large hospital systems, group purchasing organizations, and academic medical centers.